CLSN short position, 9,174,334 shares as of May 31, over 20% of the float
It's probably more today. Once the conferences are over, the data distributed and peer reviewed, once China submits for SFDA approval (they are working on it now), then, how will that insanely large short position cover?
It's not going to zero you dopes! CLSN has 50 million dollars in cash, which is 4 years operating capital, 2 more ongoing trials, and a probable marketing deal in China. Their data is being presented at ECIO this week, will be peer reviewed, and the subgroup of 300 patients with a 66% improvement in Overall Survival will be tweeked to get an FDA submission filed!
Only a fool shorts a stock at $1.25 with all that going for it. It can be $9 again in 3 days, just like it was in January.
Eventually your naked shorts will get called in. You are playing a game of musical chairs. Don't get caught without a seat at the table.